These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 10287653)

  • 21. [Is imputation in drug surveillance reliable?].
    Girard M
    Therapie; 1984; 39(3):291-6. PubMed ID: 6463954
    [No Abstract]   [Full Text] [Related]  

  • 22. EtO emission control technology.
    Porco RD
    J Healthc Mater Manage; 1988; 6(8):52, 54. PubMed ID: 10290876
    [No Abstract]   [Full Text] [Related]  

  • 23. Standardize and synchronize product data for safety.
    Perry R
    Hosp Mater Manage; 2007 May; 32(5):2. PubMed ID: 17526398
    [No Abstract]   [Full Text] [Related]  

  • 24. Adverse drug reactions.
    Turner P
    Hum Toxicol; 1986 May; 5(3):161-2. PubMed ID: 3710492
    [No Abstract]   [Full Text] [Related]  

  • 25. Postmarketing follow-up: physicians have key role.
    Goldsmith MF
    JAMA; 1985 Oct; 254(16):2217. PubMed ID: 4046146
    [No Abstract]   [Full Text] [Related]  

  • 26. [Notification of possible adverse reactions to drugs in medical publications].
    Laporte JR; Capellà D
    Med Clin (Barc); 1984 Oct; 83(11):474. PubMed ID: 6503426
    [No Abstract]   [Full Text] [Related]  

  • 27. [How to report side-effects of drugs?].
    Guillaume JC
    Ann Dermatol Venereol; 1986; 113(4):375-6. PubMed ID: 3767239
    [No Abstract]   [Full Text] [Related]  

  • 28. [Drug surveillance. Which methods? For which adverse effects? Application to teratogen monitoring].
    Goujard J
    Therapie; 1985; 40(5):287-92. PubMed ID: 4095683
    [No Abstract]   [Full Text] [Related]  

  • 29. How managers can evaluate new sterilization technologies.
    Reichert M
    OR Manager; 1994 Aug; 10(8):9-11. PubMed ID: 10136170
    [No Abstract]   [Full Text] [Related]  

  • 30. [Bayesian approach to the imputability of undesirable phenomena to drugs].
    Auriche M
    Therapie; 1985; 40(5):301-6. PubMed ID: 4095686
    [No Abstract]   [Full Text] [Related]  

  • 31. [Necessity and difficulties of quantitative drug monitoring].
    Lagier G; Dally S; Vincens M; Castot A
    Therapie; 1983; 38(3):319-23. PubMed ID: 6612668
    [No Abstract]   [Full Text] [Related]  

  • 32. [A network of regional correspondents for studying undesirable effects].
    Haramburu F; Péré JC; Begaud B; Albin H
    Therapie; 1985; 40(5):321-4. PubMed ID: 4095688
    [No Abstract]   [Full Text] [Related]  

  • 33. [Sensitivity and specificity of imputability criteria. Study and comparison of these efficacity indices for 7 methods].
    Péré JC; Godin MH; Bégaud B; Haramburu F; Albin H
    Therapie; 1985; 40(5):307-12. PubMed ID: 4095687
    [No Abstract]   [Full Text] [Related]  

  • 34. Expert users' monitoring practices.
    OR Manager; 1988 Mar; 4(3):8. PubMed ID: 10286086
    [No Abstract]   [Full Text] [Related]  

  • 35. A "complaint department" for medical devices.
    Thompson RC
    FDA Consum; 1987 Mar; 21(2):10-3. PubMed ID: 10312180
    [No Abstract]   [Full Text] [Related]  

  • 36. Comparison of in-hospital and industrial sterilization of medical devices.
    Young JH
    J Healthc Mater Manage; 1986; 4(2):30-4. PubMed ID: 10275922
    [No Abstract]   [Full Text] [Related]  

  • 37. [Imputability in drug monitoring. Principles of the balanced drug reaction assessment method and principal errors to avoid].
    Lagier G; Vincens M; Castot A
    Therapie; 1983; 38(3):303-18. PubMed ID: 6612667
    [No Abstract]   [Full Text] [Related]  

  • 38. Postmarketing studies of drug efficacy: when must they be randomized?
    Strom BL; Miettinen OS; Melmon KL
    Clin Pharmacol Ther; 1983 Jul; 34(1):1-7. PubMed ID: 6861430
    [No Abstract]   [Full Text] [Related]  

  • 39. [Drug monitoring].
    Royer RJ
    Bull Soc Ophtalmol Fr; 1985 Nov; Spec No():11-30. PubMed ID: 4064240
    [No Abstract]   [Full Text] [Related]  

  • 40. Techniques of postmarketing surveillance. An overview.
    Carson JL; Strom BL
    Med Toxicol; 1986; 1(4):237-46. PubMed ID: 3537618
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.